Societies push standards for robotic surgery

CHICAGO (Reuters) - Surgeons are increasingly opting for robotic surgery over conventional surgery, such as Intuitive Surgical's popular da Vinci Surgical System, especially for removing the prostate gland. There were some 80,000 robotic prostatectomy procedures in the United States last year.

The rate of failure for such surgeries is comparable to that of traditional surgeries but patients are more at risk if inexperienced surgeons use the robots.

"The more you do, the better you're going to get. The question is at what point are you doing safe surgery," said Dr. Kevin Zorn, chief of urology at Weiss Memorial Hospital at the University of Chicago.

Dr. Zorn was lead author of an article in the September issue of the Journal of Urology that proposed instituting training standards for surgeons using the equipment. Currently, there is no credentialing system to evaluate a surgeon's competency and surgeons cannot practice on simulators. Dr. Zorn believes such machines ought to exist.

He recounted one case of a surgeon who was using the system for the fourth time. After eight hours, a more experienced surgeon who was supervising the operation told the surgeon that progress was too slow. He recommended the surgeon switch to an open approach. After the senior surgeon left the room, the less experienced surgeon continued using the robot. The patient later died from complications.

The issue of standards will be addressed at next month's World Congress of Endourology in Munich. The American Urology Association (AUA) will consider the recommendations.

Some scientists believe doctors, especially in the United States, are too eager to operate in cases of prostate cancer and would often do better to wait to see if tumors develop.

As of mid-2009, there were 1,242 da Vinci Surgical Systems in place throughout the world, up from 286 in 2004. Prices range from $700,000 to $2.25 million per system.

Dr. Zorn, who said he has performed more than 500 robot-assisted surgeries, estimates that surgeon must use the system at least 20 times before becoming familiar enough with the set-up and the procedure to do the surgery safely.

Hospitals have different guidelines and some have none, he said in an interview.

"Intuitive did a great job getting out (and) promoting it, but really didn't think about making sure we're doing safe robotic surgery," he said.

But Dr. Zorn said that surgeons, not manufacturers, carry ultimate responsibility for proper training.

Ben Gong, vice president of finance at Intuitive, agreed, saying that while the company is committed to training, it is not the manufacturer's responsibility to set standards.

"That's up to the hospitals and the medical societies. We work very closely with the medical societies," Gong said. "We are in favor of more training. We are all about training, and we put a lot of money and resources into training."

Dr. Zorn, who has served as an expert witness in court actions and as a proctor, said robotic surgery can take longer than it should if the surgeon is still learning the equipment.

"If you're not good at the surgery and you don't know what you are doing, it could take you twice as long," he said.

Reports indicate, however, that robotic surgery results in less trauma, blood loss, risk of infection, scarring and pain. Hospital stays are also generally shorter.

"Robotic surgery is a major improvement," said Dr. H. Pat Hezmall, director of USMD Prostate Cancer Center in Arlington, Texas. "The patient is home eating dinner that night."

"Patients are demanding it," added Dr. Michael McGuire, surgical director of Urology Oncology and co-director of the Prostate Cancer Center at Northshore University Health Systems in suburban Chicago.

As many as nine out of 10 prostate cancer patients who opt for surgery prefer robotic-assisted surgery, said McGuire, who has done hundreds of procedures.

"If you don't do robotic surgery, you may as well get out of the prostate surgery business," McGuire said.

.

Copyright © 2009 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.